Back
ProShares UltraShort QQQ Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
54
QID
ProShares UltraShort QQQ
Last Price:
$38.05
Seasonality Move:
-11.47%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Buy
54
ProShares UltraShort QQQ (QID)
is a Buy
Is ProShares UltraShort QQQ a Buy, Sell or Hold?
-
The current ProShares UltraShort QQQ [QID] share price is $38.05. The Score for QID is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
QID is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
QID Stock Price Chart
What is ProShares UltraShort QQQ's stock price today?
-
The ProShares UltraShort QQQ share price today is $38.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QID is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.46The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
QID Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1 | Buy |
Relative Strength Index (14 RSI): | 61.46 | Buy |
Chaikin Money Flow: | 6349631 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.34 - 37.48) | Buy |
Bollinger Bands (100): | (30.72 - 35.26) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.41 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 78938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.82 - 268.04) | Buy |
Bollinger Bands (100): | (240.65 - 270.25) | Buy |
QID Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.3 | Buy |
20-day SMA: | 36.18 | Buy |
50-day SMA: | 33.12 | Buy |
200-day SMA: | 35.72 | Buy |
8-day EMA: | 36.47 | Buy |
20-day EMA: | 35.72 | Buy |
50-day EMA: | 34.23 | Buy |
200-day EMA: | 37.32 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 271.33 | Sell |
20-day SMA: | 255.41 | Buy |
50-day SMA: | 259.88 | Buy |
200-day SMA: | 253.94 | Buy |
8-day EMA: | 268.64 | Sell |
20-day EMA: | 261.32 | Buy |
50-day EMA: | 257.88 | Buy |
200-day EMA: | 244.57 | Buy |
ProShares UltraShort QQQ Earnings Growth & QID Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
ProShares UltraShort QQQ Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |